Is The Cross-Species Organ Transplantation Market Expected To Reach $22.65 Billion While Growing At 8.2% CAGR By 2030?

 

What Market Size Is Projected For The Cross-Species Organ Transplantation Market By 2030?
 The cross-species organ transplantation market size has grown strongly in recent years. It will grow from $15.2 billion in 2025 to $16.5 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to shortage of human donor organs, early-stage xenotransplant research initiatives, advancements in genetic engineering tools, preclinical validation of animal-derived organs, increasing transplant waiting lists.
 
 The cross-species organ transplantation market size is expected to see strong growth in the next few years. It will grow to $22.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing clinical trial activity in xenotransplantation, rising investment in gene-edited animal models, growing collaboration between biotech firms and transplant centers, advancements in immunosuppressive therapies, expanding regulatory frameworks for xenotransplants. Major trends in the forecast period include increasing advancements in genetically engineered donor organs, growing focus on immune rejection mitigation strategies, expansion of organ preservation and perfusion technologies, rising investment in translational xenotransplant research, enhanced regulatory and ethical oversight.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp
 
 Which Primary Market Drivers Are Fueling Momentum In The Cross-Species Organ Transplantation Market?
 The growing shift towards genetic engineering is expected to propel the growth of the cross-species organ transplantation market going forward. Genetic engineering refers to the deliberate modification of an organism’s DNA using biotechnology techniques to introduce, remove, or alter specific genes. The rise in genetic engineering is due to the urgent need to address organ shortages by creating animal organs that are more compatible for human transplantation. Genetic engineering supports the growth of cross-species organ transplantation by enabling the modification of animal organs to reduce immune rejection, making them suitable for human transplants. For instance, in July 2023, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, there were 247 gene therapies in Phase II by the end of first quarter of 2023, increasing by 5% to reach 260 by the end of the second quarter. Therefore, the growing shift towards genetic engineering is driving the growth of the cross-species organ transplantation market.
 
 What Major Market Segments Contribute To Shaping The Overall Framework Of The Cross-Species Organ Transplantation Market?
 The cross-species organ transplantation market covered in this report is segmented — 
 
 1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types
 2) By Application: Kidney, Heart, Liver, Lung, Other Applications
 3) By End-User: Transplant Centers, Hospitals, Other End-Users
 
 Subsegments:
 1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions 
 2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays 
 3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants 
 4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices
 
 What Influential Trends Are Gaining Momentum Within The Cross-Species Organ Transplantation Market?
 Major companies operating in the cross-species organ transplantation market are focusing on adopting strategic partnerships to streamline the regulatory approval process for xenotransplantation solutions. A strategic partnership is an alliance where companies work together to achieve common goals by utilizing each other’s strengths and resources, aiming to boost growth, innovation, and competitiveness without merging. For instance, in February 2025, United Therapeutics, a US-based biotechnology company, and eGenesis, a US-based pharmaceutical company to begin clinical trials for pig kidney (xenotransplant) transplants in humans. This trial received approval from the U.S. Food and Drug Administration (FDA) to transplant genetically modified pig kidneys into patients with kidney failure. The trials aim to address the critical shortage of donor kidneys by potentially providing a new, sustainable organ source for those in need.
 
 Who Are The Established And Emerging Players Expanding Their Footprint In The Cross-Species Organ Transplantation Market?
 Major companies operating in the cross-species organ transplantation market are Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc., Revivicor Inc., XVIVO Perfusion AB, Bridge To Life Ltd, Transplant Genomics Inc. 
 
 Get Your In-Depth Cross-Species Organ Transplantation Market Report Now:
 https://www.thebusinessresearchcompany.com/report/cross-species-organ-transplantation-global-market-report
 
 Which Regional Clusters Are Forecasted To Outperform Others In The Cross-Species Organ Transplantation Market?
 North America was the largest region in the cross-species organ transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company